Status:
COMPLETED
Biological Effects of Treatment With Resveratrol in ART Patients
Lead Sponsor:
University Of Perugia
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
To evaluate the effects of a new nutraceutical formulation containing resveratrol (trademark GENANTE) on gamete quality in order to improve the reproductive process during ART.
Detailed Description
The purpose of the study is to evaluate the effect of a new nutraceutical formulation containing resveratrol (trademark Genante) on gamete quality in order to improve the reproductive protocols during...
Eligibility Criteria
Inclusion
- Women with a diagnosis of infertility
- BMI between 18 and 30 kg/m2,
- regular uterine cavity
- normal thyroid function
- normal blood parameters
Exclusion
- primary or secondary ovarian failure
- patients who adhered to Bologna Criteria (at least two of the following: advanced maternal age \>40, less than 3 oocytes recovered in previous attempts, abnormal ovarian reserve test)
- presence of ovaries inaccessible to the oocyte pick-up,
- persistent ovarian cysts \> 20 mm,
- presence of sactosalpinx
- heterologous fertilization, significant systemic disease or other situations unsuitable for ovarian stimulation
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04386499
Start Date
January 10 2019
End Date
May 5 2020
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Perugia, Piazza Menghini 1, S. Andrea delle Fratte.
Perugia, Umbria, Italy, 06156